Intensity Therapeutics Inc. (INTS)
NASDAQ · Healthcare
Intensity Therapeutics Inc. EBITDA 2020–2025
Intensity Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Intensity Therapeutics Inc. ebitda for the quarter ending March 31, 2026 was -2.5 M, a 25.57% decrease year-over-year.
- Intensity Therapeutics Inc. ebitda for the twelve months ending March 31, 2026 was -11.1 M.
- Intensity Therapeutics Inc. annual ebitda for 2025 was -12.0 M, a 26.41% decrease from 2024.
- Intensity Therapeutics Inc. annual ebitda for 2024 was -16.3 M, a 104.09% increase from 2023.
- Intensity Therapeutics Inc. annual ebitda for 2023 was -8.0 M, a 6.28% increase from 2022.
- Intensity Therapeutics Inc. annual ebitda for 2022 was -7.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Intensity Therapeutics Inc. EBITDA — FAQ
Intensity Therapeutics Inc. (INTS) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INTS's ebitda history?
The chart and table above show Intensity Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.